Enuresis. nonorganic enuresis
Conditions
Interventions
Intervention 1: Desmopressin Acetate tablets are used sublingually from FERRING Company under the brand name of MELT , for patients under 7 years of age, the dose is 60 micrograms, and for patients ov
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: 6 to 12 years old Single-symptom nocturnal enuresis Able to use nasal spray or sublingual tablets Completion of the informed consent form by the guardian or legal guardian At least two weeks before the start of the study, he did not receive any medicine
Exclusion criteria
Exclusion criteria: Having a history of organic urological disease, daily urinary incontinence, diabetes insipidus, or persistent urinary tract infection Having clinically significant renal, hepatic, gastrointestinal, pulmonary, cardiovascular, endocrine, or neurological disease that interferes with evaluation Using antibiotics, diuretics or any medicine that affects the concentration of urine Failure to complete the informed consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nocturia frequency. Timepoint: The period before the study, during one month after starting the drug and the follow-up period three months later. Method of measurement: Recording wet or dry nights in a notebook, by parents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Saadat
Mashhad University of Medical Sciences
Outcome results
None listed